GE HealthCare said Friday it received Food and Drug Administration clearance for its artificial intelligence tool that uses ...

The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

The full-year tariff impact of 85 cents per share would have more than doubled without mitigation actions underway, ...

GE HealthCare trimmed its financial forecasts for the remainder of the year in the face of U.S. | GE HealthCare said that ...

For its full year, GE HealthCare said it expects to report adjusted earnings in the range of $3.90 to $4.10 per share, which is a decline of 13% to 9% from its guide last quarter. The company said the ...

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q1 CY2025 results , with sales up 2.8% year ...

GE HealthCare Technologies Inc. GEHC is scheduled to report first-quarter 2025 results on April 30, before market open. In ...

GE HealthCare Technologies Inc.’s GEHC share price has surged by 7.68%, which has investors questioning if this is right time ...

A GE Hitachi Nuclear-led research team successfully tested new ... issued the construction permit to the company for its SMR on April 4. RadWaste & Materials Monitor RadWaste & Materials Monitor ...

GE HealthCare is a trusted partner and leading ... help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 ...